Send feedback

BLK p.Asp327Val

c.980A>T · rs138333004 · VCV910816

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.1381 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0227%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
maturity-onset diabetes of the young type 11

Computational evidence

Protein change
AlphaMissense0.1381likely benign
REVEL0.128moderately benign-leaning
SaProtLLR -8.75tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI<0.2all four deltas below 0.2 · A>G here scores Δ0.28 · evaluated, not missing
Constraint at this position
ConservationphyloP 8GERP -0.25, phastCons 1
Regional constrainto/e 1.29unconstrained · MANE · 21 kb · p 7e-14 · regional, not allelic
Overall
CADD20.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0227% European (non-Finnish) · 268/1,179,960 alleles
Filtering AF 0.0204% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0195%
Overall 0.0199% 321/1,613,978 alleles · ultra-rare exomes 285/1,461,770 · genomes 36/152,208 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.0547% 1,829
European (non-Finnish)grpmax 0.0227% 4,403
Remaining individualsnot grpmax-eligible 0.0192% 5,206
Admixed American 0.01% 10,002

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
BLK
Protein
p.Asp327Val
Coding
c.980A>T
MANE Select
NM_001715
dbSNP
rs138333004
Type
single nucleotide variant
Location
chr8:11557989 (GRCh38)
Gene constraint
LOEUF 1.295 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 81.89
Residue 327
the protein kinase domain
Full BLK gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

maturity-onset diabetes of the young type 11 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For MODY (Orphanet):

Inheritance
Autosomal dominant, Not applicable
Onset
Adolescent, Adult, Childhood
Prevalence
1-5 / 10 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/blk-p-asp327val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown